Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B | Zendy

Mio Tanaka | Zendy; Fumitaka Suzuki | Zendy; Yuya Seko | Zendy; Tasuku Hara | Zendy; Yusuke Kawamura | Zendy; Hitomi Sezaki | Zendy; Tetsuya Hosaka | Zendy; Norio Akuta | Zendy; Masahiro Kobayashi | Zendy; Yoshiyuki Suzuki | Zendy; Satoshi Saitoh | Zendy; Yasuji Arase | Zendy; Kenji Ikeda | Zendy; Mariko Kobayashi | Zendy; Hiromitsu Kumada | Zendy

Open Access

Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B

Author(s) -

Mio Tanaka,

Fumitaka Suzuki,

Yuya Seko,

Tasuku Hara,

Yusuke Kawamura,

Hitomi Sezaki,

Tetsuya Hosaka,

Norio Akuta,

Masahiro Kobayashi,

Yoshiyuki Suzuki,

Satoshi Saitoh,

Yasuji Arase,

Kenji Ikeda,

Mariko Kobayashi,

Hiromitsu Kumada

Publication year - 2013

Publication title -

journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.33

H-Index - 114

eISSN - 1435-5922

pISSN - 0944-1174

DOI - 10.1007/s00535-013-0779-0

Subject(s) - hypophosphatemia , adefovir , medicine , lamivudine , gastroenterology , renal function , creatinine , hepatology , fanconi syndrome , kidney , hepatitis b virus , immunology , virus

Renal dysfunction and Fanconi's syndrome associated with hypophosphatemia caused by long-term administration of low-dose adefovir dipivoxil (ADV) has been reported in recent years. The aim of this retrospective study was to determine the incidence and factors associated with renal dysfunction and hypophosphatemia in patients with hepatitis B infection on long-term treatment with ADV and lamivudine (LAM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research